Table 1.
Study | Selection | Comparability | Outcome or Exposure | Total |
---|---|---|---|---|
Case-Control Studies | ||||
Alavez-Rubio 2020 [33] | *** | ** | ** | 7 |
Arboleda 2001 [24] | ** | ** | * | 5 |
Bartrés-Faz 2001 [34] | **** | * | 5 | |
Campos 2013 [5] | *** | ** | * | 6 |
Jacquier 2001 [21] | *** | ** | * | 6 |
Cristiá-Lara 2017 [35] | **** | ** | ** | 8 |
Forero 2006 [22] | *** | ** | * | 6 |
Mateo 2002 [37] | **** | * | 5 | |
Moreno 2017 [23] | **** | ** | ** | 8 |
Sevush 2000 [29] | **** | * | * | 6 |
Teruel 2011 [36] | **** | ** | ** | 8 |
Villalpando-Berumen 2008 [31] | **** | ** | * | 7 |
Marca-Ysabel 2021 [25] | **** | ** | * | 7 |
Aguilar-Navarro 2021 [32] | *** | ** | * | 6 |
Cohort Studies | ||||
Granot-Hershkovitz 2020 [6] | *** | ** | * | 6 |
Allegri 2018 [27] | **** | ** | ** | 8 |
Molero 2001 [26] | **** | ** | * | 7 |
Villarreal 2016 [38] | **** | ** | ** | 8 |
O'Bryant 2013 [28] | **** | ** | ** | 8 |
Tosto 2015 [30] | *** | ** | ** | 7 |
Newcastle-Ottawa-Scale scores for the risk of bias assessment of included studies.
Case-Control: Selection (max 4 stars): (1) Is the case definition adequate? (2) Representativeness of the cases (3) Selection of Controls (4) Definition of Controls Comparability (max 2 stars): (1) Comparability of cases and controls on the basis of the design or analysis- A. study controls for the most important factor (*) B. study controls for any additional factor (*) Exposure (max 3 stars): (1) Ascertainment of exposure (2) Same method of ascertainment for cases and controls (3) Non-response rate
Cohort: Selection (max 4 stars): (1) Representativeness of the exposed cohort (2) Selection of the non-exposed cohort (3) Ascertainment of exposure (4) Demonstration that outcome of interest was not present at start of study Comparability (max 2 stars): (1) Comparability of cohorts on the basis of the design or analysis- A. study controls for the most important factor (*) B. study controls for any additional factor (*) Outcome (max 3 stars): (1) Assessment of outcome (2) Was follow-up >5 years (3) Adequacy of follow up of cohorts